JAKARTA - Prixa, a leading healthcare technology company, recently secured additional USD 3 million in funding, led by MDI Ventures (MDI) and Trans-Pacific Technology Fund (TPTF) with participation from existing investors including Siloam Hospitals Group. This funding will be used to expand the reach of Prixa's platform and user base, support Prixa's B2B customer base, and increase accessibility to healthcare and the digital transformation of Indonesia's healthcare services.
Prixa was founded in 2019 and is led by James Roring, MD. The company was first launched with an Artificial Intelligence (AI) based health management platform that provides telemedicine and other basic primary care services to healthcare payers with the mission of humanizing healthcare by leveraging data and technology. The Prixa platform allows users to connect directly with primary care services, which include telemedicine consultation, drug delivery, and on-demand laboratory tests.
Barry Lee, Managing Director of the Trans-Pacific Technology Fund said, “As an international venture fund, we see a significant opportunity to support the healthcare industry in Indonesia through cutting-edge technology. We look forward to contributing the global experience in this sector that we gain from our portfolio of other health technology companies to support Prixa's growth."
Prixa focuses on healthcare payer services, which include insurance companies, corporations, and government entities; currently serving about 10 million users. With the aim of reducing claims costs and healthcare costs, Prixa strives to provide healthcare in a paradigmatic way through a managed care approach. This business model is also in line with Prixa's support for government programs for digital transformation in the healthcare sector and for improving health services across all levels of society. (LM)